Shoshana Shendelman - 14 Dec 2021 Form 4/A - Amendment Insider Report for Applied Therapeutics Inc. (APLT)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Shoshana Shendelman
Issuer symbol
APLT
Transactions as of
14 Dec 2021
Net transactions value
$0
Form type
4/A - Amendment
Filing time
11 Jan 2022, 17:42:58 UTC
Date Of Original Report
16 Dec 2021
Previous filing
14 Sep 2021
Next filing
11 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLT Common Stock Award $0 +120,900 +33% $0.000000 485,186 14 Dec 2021 Direct F1
holding APLT Common Stock 1,750,000 14 Dec 2021 See footnote F2
holding APLT Common Stock 1,492,094 14 Dec 2021 See footnote F3
holding APLT Common Stock 709,720 14 Dec 2021 See footnote F4
holding APLT Common Stock 290,280 14 Dec 2021 See footnote F5
holding APLT Common Stock 88,397 14 Dec 2021 See footnote F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of compensatory Restricted Stock Units granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. Each compensatory Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. One-fourth (1/4th) of the compensatory Restricted Stock Units shall vest on December 14, 2022, and one-twelfth (1/12th) of the remaining shares subject to the compensatory Restricted Stock Units shall vest each quarter thereafter, subject to the Reporting Person continuing to provide services through each such date.
F2 Through a grantor retained annuity trust.
F3 Through a family trust controlled by the reporting person's spouse.
F4 Through the reporting person's spouse.
F5 Through a family trust controlled by the reporting person.
F6 Through Clearpoint Strategy Group LLC of which the reporting person is the sole owner.

Remarks:

This amendment is being filed solely to correct the vesting schedule for the compensatory Restricted Stock Units reported on the Reporting Person's Form 4 filed on December 16, 2021.